TL Genomics Investors
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.
Connections
Investor Type:
Healthcare Company
Founded Date:
2015
Industry:
Deep Diagnostics
Employee Number:
11-50
Headquarters:
Koganei, Tokyo, Japan